During the past decade, Tsujinaka Hospital Kashiwanoha conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tsujinaka Hospital Kashiwanoha" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tsujinaka Hospital Kashiwanoha" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tsujinaka Hospital Kashiwanoha" are "Ulcerative Colitis" (8 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (2 trials), "Crohn Disease" (1 trials) and "Fistulizing Crohns Disease" (1 trials). Many other conditions were trialed in "Tsujinaka Hospital Kashiwanoha" in a lesser frequency.

Most popular intervention types in "Tsujinaka Hospital Kashiwanoha" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Etrasimod" (4 trials), "Guselkumab" (3 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tsujinaka Hospital Kashiwanoha" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Tsujinaka Hospital Kashiwanoha". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tsujinaka Hospital Kashiwanoha, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tsujinaka Hospital Kashiwanoha, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".